2014 Feb
In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid (MPTP/P)-induced Parkinsons disease model mice, MPTP/P injection increased the ratio of Bax/Bcl-2 and the expression of caspase-3 in the hippocampus, while berberine administration reversed these effects ( In addition, animal experiments and cell experiments have confirmed that berberine reduces the levels of extracellular and intracellular A, increases the levels of LC3-II, Beclin-1, hVps34 and cathepsin-D, and reduced the levels of P62, Bcl-2, amyloid precursor protein (APP), and beta-secretase 1 (BACE1)
This approach reduces nausea, vomiting, and gastrointestinal discomfort that commonly occur when patients begin weight loss medications at full strength
Almengl C, Devesa P, Devesa J, Arce VM
Navigating Initial Fatigue on Semaglutide Semaglutide, a GLP-1 weight loss medication, could cause some discomfort, such as fatigue, after you start taking it